For the quarter ending 2025-09-30, KRRO has $161,550K in assets. $62,518K in debts. $24,155K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 24,155 | 33,612 | ||
| Short-term marketable securities | 68,324 | 62,750 | ||
| Accounts receivable | 820 | 1,089 | ||
| Prepaid expenses and other current assets | 4,927 | 5,183 | ||
| Total current assets | 98,226 | 102,634 | ||
| Total property and equipment, gross | 35,357 | - | ||
| Less accumulated depreciation | 10,959 | - | ||
| Property and equipment, net | 24,398 | 25,395 | ||
| Operating lease right-of-use assets | 23,332 | 23,510 | ||
| Restricted cash, net of current portion | 2,409 | 2,409 | ||
| Long-term marketable securities | 10,014 | 23,264 | ||
| Other non-current assets | 3,171 | 3,213 | ||
| Total assets | 161,550 | 180,425 | ||
| Accounts payable | 2,300 | 5,163 | ||
| Accrued expenses and other current liabilities | 5,861 | 5,659 | ||
| Operating lease liabilities, current portion | 3,145 | 2,425 | ||
| Deferred revenue, current portion | 3,332 | 3,926 | ||
| Total current liabilities | 14,638 | 17,173 | ||
| Operating lease liabilities, net of current portion | 41,523 | 42,207 | ||
| Deferred revenue, non current portion | 4,825 | 4,502 | ||
| Other non-current liabilities | 1,532 | 1,440 | ||
| Total liabilities | 62,518 | 65,322 | ||
| Common stock, 0.001 par value 200,000,000 shares authorized at september 30, 2025 and december 31, 2024 9,397,984 shares and 9,377,259 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 9 | 9 | ||
| Additional paid-in capital | 432,613 | 430,660 | ||
| Accumulated other comprehensive income | 214 | 177 | ||
| Accumulated deficit | -333,804 | -315,743 | ||
| Total stockholders' equity | 99,032 | 115,103 | ||
| Total liabilities and stockholders' equity | 161,550 | 180,425 | ||
Korro Bio, Inc. (KRRO)
Korro Bio, Inc. (KRRO)